2009 Individual IT Medical 
The Clinical Problem Solvers
JANUARY 18, 2021
Understand that collective action and a focus on community, rather than individualism, are most effective in combating racism and achieving health equity. One of the biggest barriers to health equity is the narrow focus on the individual and a failure to see health as a widespread community issue.
FDA Law Blog
OCTOBER 9, 2022
The president’s first step was a pardon of all prior federal offenses of simple marijuana possession and a direction to the Attorney General to develop an administrative process to issue certificates of pardon to eligible individuals. HHS has undertaken scientific and medical evaluations of marijuana in recent years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
AUGUST 2, 2022
As a reminder, cannabis remains a schedule I substance under the federal Controlled Substances Act (“CSA”), which by definition means it does not have an accepted medical use in treatment in the United States and thus cannot be legally sold or marketed for any purpose. 21 U.S.C. § 812(b)(1). 26, 2022).
The Clinical Problem Solvers
DECEMBER 16, 2020
Our guests explain how we can incorporate race-conscious medicine in clinical settings, medical education, and biomedical/epidemiological research to responsibly recognize and address the harms of racial inequality. Nwamaka Eneanya and Jennifer Tsai to discuss the limitations and harms of race-based medicine in clinical practice.
GeriPal
OCTOBER 13, 2022
Alex: And we are also delighted to welcome Devika Nair, who is a nephrologist at Vanderbilt University Medical Center in Tennessee Valley VA Healthcare System. That includes many medical specialists, surgical specialists, many specialists and many other disciplines who are on our older adults team. Eric: Welcome to the GeriPal podcast.
FDA Law Blog
FEBRUARY 27, 2024
Consequently, because both applications were approved at the same time, both applications represent the first permitted commercial marketing or use of the product or the individual active ingredients, as outlined under 35 U.S.C. leave you scratching your head (we’ll call it “Who’s Buried in Grant’s Tomb?”). l 56(c)(4) and 37 C.F.R.
GeriPal
MARCH 2, 2023
This long and sordid history of gabapentin and pregabalin is beautifully described in Seth Landefeld and Mike Steinman 2009 NEJM editorial. By 2015 that number increased to 4% of US adults. There are a lot of reasons that may explain the massive increase in use of these drugs. Cochrane Database of Systematic Reviews Review. Annals of IM.
Expert insights. Personalized for you.
52 
Let's personalize your content